Glaxo appoints new chief executive
One of the world’s largest pharmaceutical firms GlaxoSmithKline today announced a replacement for chief executive Jean-Paul Garnier.
Andrew Witty, 43, currently president for Glaxo’s European pharmaceuticals arm, will succeed Mr Garnier when he retires at the end of May.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





